KKR heads into its August 4 earnings report with an unusual ownership dynamic: its own Co-CEOs and directors bought shares aggressively during February and March's sell-off, yet the stock at $91.78 remains below every level they paid.
The insider buying cluster is the standout feature of this note. Both Co-CEOs moved in size during the February drawdown. Scott Nuttall spent roughly $17.2 million across multiple tranches at prices between $87.81 and $102.87. Joseph Bae added approximately $10.7 million over the same window at similar levels. Director Timothy Barakett followed in early March with a $4.7 million purchase at $94.47. A director, Mary Dillon, also bought $2 million. In aggregate, net insider purchases over the 90-day window totalled more than $50.9 million and 516,000 shares — nearly every transaction a buy, none a sale. The Co-CEOs' average cost basis sits above today's close, meaning they are currently underwater on those trades. That does not change the signal; it amplifies the question of when the gap closes.
The lending market offers no meaningful signal here, and that is itself worth noting. Borrow availability on KKR is effectively unlimited — the lending pool has more than 425 million shares available, dwarfing the 15.4 million shares currently held short. Short interest, at just 1.7% of free float, has crept up about 19% over the past month but from a trivially low base. Cost to borrow is a negligible 0.36%, up about 14% on the week but still consistent with a stock that is almost friction-free to short. The ORTEX short score of 33 reflects the same picture: there is no meaningful short-side pressure, and no squeeze tension to speak of. Options positioning is structurally elevated — the put/call ratio is running near 1.94, close to its 20-day average and well above 1.0 — but this appears to be a persistent feature of KKR's options market rather than a recent defensive shift. The z-score is just 0.15, essentially at the mean.
The Street remains constructive but has been trimming targets since April. Analysts with positive ratings — including Overweight calls from Morgan Stanley, Barclays, and Piper Sandler — cut price targets sharply in April as macro uncertainty peaked, with Goldman Sachs lowering its Buy-rated target from $145 to $110. After the May earnings print, UBS lifted its Buy target from $113 to $126, while TD Cowen's Hold target moved modestly. The consensus mean now sits near $127, implying roughly 38% upside from the current price — a wide gap that reflects both the scale of the April cuts and the stock's subsequent underperformance. The bull case centres on fee-related earnings momentum: management fees up 30% year-on-year, FRE per share up 23%, and the insurance segment growing 12%. Bears point to back-end weighted realisation guidance for 2026, estimates running 2-8% below consensus, and sensitivity to capital markets conditions. The forward 12-month EPS trajectory ranks in the 80th percentile on ORTEX factor scores, but near-term EPS momentum over 90 days has softened to the 22nd percentile — the Street's enthusiasm for the growth story is intact, but confidence in the near-term delivery has moderated.
KKR's closest peers also had a difficult week. ARES fell 7.8%, BAM dropped 4.6%, and STEP shed 3.7%. BX and CG lost roughly 2% each. TPG was the exception, gaining 2.5% — the only name in the group to close the week in positive territory. KKR's own 1.8% weekly decline was therefore a relative outperformance against the peer group median, even if the stock remains 4.3% lower over the past month.
The recent earnings history adds a note of caution into August 4. The last two quarterly prints each produced a negative next-day reaction — the May print saw the stock fall 0.3% on the day and barely move over the following week, while the prior quarter delivered a 2.5% one-day drop and a 3.7% five-day loss. The pattern is mild rather than dramatic, but it is consistently negative on realisation day. With the Co-CEOs' open-market buys still underwater, the August print represents the clearest near-term test of whether the insider conviction and the Street's upside targets can begin to reconnect with the price.
See the live data behind this article on ORTEX.
Open KKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
